Commercial Int Bank - Consolidated Financial Position at March 31.2025
RNS Number : 4189I Commercial Intnl Bank (Egypt) SAE 13 May 2025 Click on, or paste the following link into your web browser, to view the associated PDF document. http://www.rns-pdf.londonstockexchange.com/rns/4189I_1-2025-5-13.pdf Condensed Consolidated Interim Statement of Financial Position as at March 31, 2025
| Notes | Mar. 31, 2025 | Dec. 31, 2024 | ||
| Assets | ||||
| Cash and balances at the central bank | 9 | 68,810,514 | 136,531,020 | |
| Due from banks | 10 | 314,305,928 | 270,829,834 | |
| Loans and advances to banks, net | 12 | 16,109,873 | 9,555,410 | |
| Loans and advances to customers, net | 13 | 364,274,475 | 343,542,674 | |
| Derivative financial instruments | 930,893 | 819,711 | ||
| Financial investments | ||||
| - Financial Assets at Fair Value through OCI | 14 | 261,161,290 | 234,512,167 | |
| - Financial Assets at Amortized cost | 14 | 189,243,425 | 168,118,219 | |
| Investments in associates | 15 | 35,384 | 98,193 | |
| Other assets | 16 | 40,510,451 | 44,282,773 | |
| Deferred tax assets | 2,804,720 | 2,685,331 | ||
| Property and equipment | 17 | 4,698,499 | 3,997,929 | |
| Total assets | 1,262,885,452 | 1,214,973,261 | ||
| Liabilities and equity | ||||
| Liabilities | ||||
| Due to banks | 18 | 4,321,002 | 2,034,885 | |
| Due to customers | 19 | 1,000,617,577 | 972,595,958 | |
| Non-current liabilities held for sale | 30.2 | 1,397 | 1,397 | |
| Derivative financial instruments | 78,314 | 100,571 | ||
| Current income tax liabilities | 5,565,862 | 18,327,968 | ||
| Other liabilities | 20 | 46,045,132 | 21,441,169 | |
| Issued debt instruments | 21 | 5,044,951 | 5,067,781 | |
| Other loans | 23,948,624 | 23,962,389 | ||
| Other provisions | 22 | 19,045,051 | 18,621,822 | |
| Total liabilities | 1,104,667,910 | 1,062,153,940 | ||
| Equity | ||||
| Issued and paid capital | 30,431,580 | 30,431,580 | ||
| Reserves | 88,394,260 | 63,544,579 | ||
| Reserve for employee stock ownership plan (ESOP) | 2,184,420 | 1,868,235 | ||
| Retained earnings* | 36,940,838 | 56,791,883 | ||
| Total equity and net profit for the period / year | 157,951,098 | 152,636,277 | ||
| Non-Controlling Interest | 266,444 | 183,044 | ||
| Total NCI, equity and net profit for the period / year | 158,217,542 | 152,819,321 | ||
| Total liabilities and equity | 1,262,885,452 | 1,214,973,261 | ||
| The accompanying notes are an integral part of these financial statements. | ||||
| (Review report attached) | ||||
| *Including net profit for the period |
| Islam Zekry | Hisham Ezz Al-Arab | |||
| Group CFO & Executive Board Member | CEO & Executive Board Member | |||
| Notes | Mar. 31, 2025 | Mar. 31, 2024 | ||||
| Interest and similar income | 52,535,156 | 36,652,802 | ||||
| Interest and similar expense | (27,139,272) | (17,852,691) | ||||
| Net interest income | 25,395,884 | 18,800,111 | ||||
| Fee and commission income | 3,522,513 | 2,685,963 | ||||
| Fee and commission expense | (1,587,691) | (1,118,912) | ||||
| Net fee and commission income | 1,934,822 | 1,567,051 | ||||
| Dividend income | 12,751 | 610 | ||||
| Net trading income | 6 | 644,549 | 16,202,148 | |||
| Profits (Losses) on financial investments | 14.1 | 472,532 | 224,271 | |||
| Administrative expenses | (3,932,425) | (2,928,640) | ||||
| Other operating income (expenses) | 7 | (1,742,230) | (14,975,056) | |||
| Impairment release (charges) for credit losses | (84,032) | (1,421,114) | ||||
| Bank's share in the profits / losses of associates | (297) | 4,931 | ||||
| Profit before income tax | 22,701,554 | 17,474,312 | ||||
| Income tax expense | 27 | (6,479,828) | (5,926,187) | |||
| Deferred tax assets (Liabilities) | 27 | 411,443 | 376,765 | |||
| Net profit for the period | 16,633,169 | 11,924,890 | ||||
| Non-Controlling Interest | 1,394 | 456 | ||||
| Bank's shareholders | 16,631,775 | 11,924,434 | ||||
| Earnings per share | 8 | |||||
| Basic | 4.83 | 3.47 | ||||
| Diluted | 4.79 | 3.45 | ||||
| Islam Zekry | Hisham Ezz Al-Arab | |||||
| Group CFO & Executive Board Member | CEO & Executive Board Member | |||||
| Condensed Consolidated Interim statement of Comprehensive Income for the period ended March 31, 2025 | ||||
| Last 9 Months | Last 9 Months | |||
| Mar. 31, 2025 | Mar. 31, 2024 | |||
| Net profit for the period | 16,633,169 | 11,924,890 | ||
| Net change on financial assets at fair value through comprehensive income after tax | 2,491,322 | 1,915,786 | ||
| Cumulative foreign currencies translation differences | (169,708) | 831,452 | ||
| Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income | 841,687 | 744,813 | ||
| Total comprehensive income for the period | 19,796,470 | 15,416,941 | ||
| As follows: | ||||
| Bank's shareholders | 19,713,070 | 15,416,485 | ||
| Non-Controlling Interest | 83,400 | 456 | ||
| Total comprehensive income for the period | 19,796,470 | 15,416,941 | ||
| Condensed Consolidated Interim Cash flows for the period ended March 31, 2025 | ||||
| Notes | Mar. 31, 2025 | Mar. 31, 2024 | ||
| Cash flow from operating activities | ||||
| Profit before income tax | 22,701,554 | 17,474,312 | ||
| Adjustments to reconcile profits to net cash provided by operating activities | ||||
| Fixed assets depreciation | 17 | 773,002 | 261,427 | |
| Impairment release/charge for credit losses (Loans and advances to customers and banks) | (1,080,606) | 1,712,500 | ||
| Other provisions release/charge | 22 | 320,589 | 41,587 | |
| Impairment release/charge for credit losses (due from banks) | 141,071 | (646) | ||
| Impairment release/charge for credit losses (financial investments) | 1,023,567 | (290,740) | ||
| Impairment release/charge for other assets | - | (4,782) | ||
| Exchange revaluation differences for financial assets at fair value through OCI and AC | 212,785 | (17,328,576) | ||
| Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (13,267) | 1,130,412 | ||
| Revaluation differences impairment charge for Financial Assets at Amortized cost | 1,240 | 95,225 | ||
| Revaluation differences impairment charge for due from banks | (18) | 1,393 | ||
| Net utilized / recovered of other provisions | 22 | (520) | (4,517) | |
| Exchange revaluation differences of other provisions | 22 | 103,160 | 3,574,589 | |
| Profits/losses from selling property and equipment | 7 | (6,006) | - | |
| Profits/losses from selling financial investments at fair value through OCI | 14.1 | (195,124) | (224,271) | |
| Profits/losses from selling investments in associates | (277,408) | - | ||
| Share based payments | 316,185 | 300,000 | ||
| Bank's share in the profits / losses of associates | 297 | (4,931) | ||
| Operating profits before changes in operating assets and liabilities | 24,020,501 | 6,732,982 | ||
| Net decrease / increase in assets and liabilities | ||||
| Due from banks | 123,055,498 | 41,887,372 | ||
| Financial assets at fair value through P&L | - | (974,297) | ||
| Derivative financial instruments | (142,036) | 157,890 | ||
| Loans and advances to banks and customers | (26,205,658) | (37,541,091) | ||
| Other assets | 6,009,359 | (5,893,831) | ||
| Non-current assets held for sale | - | (244) | ||
| Due to banks | 18 | 2,286,117 | (6,928,939) | |
| Due to customers | 19 | 28,021,619 | 118,843,058 | |
| Current income tax obligations paid | (913,966) | (480,418) | ||
| Non-current liabilities held for sale | - | 1,297 | ||
| Other liabilities | 5,721,712 | 1,820,664 | ||
| Net cash generated from (used in) operating activities | 161,853,146 | 117,624,443 | ||
| Cash flow from investing activities | ||||
| Proceeds from sale of investments in associates | 226,698 | 4,782 | ||
| Payments for purchases of property, equipment and branches construction | (3,597,387) | (437,370) | ||
| Proceeds from selling property and equipment | 6,006 | - | ||
| Proceeds from redemption of financial assets at amortized cost | 2,579,713 | 285,507 | ||
| Payments for purchases of financial assets at amortized cost | (23,883,457) | (53,615,996) | ||
| Payments for purchases of financial assets at fair value through OCI | (29,279,247) | (26,592,698) | ||
| Proceeds from selling financial assets at fair value through OCI | 6,310,466 | 26,222,450 | ||
| Net cash generated from (used in) investing activities | (47,637,208) | (54,133,325) | ||
| Condensed Consolidated Interim Cash flows for the period ended March 31, 2025 (Cont.) | ||||
| Mar. 31, 2025 | Mar. 31, 2024 | |||
| Cash flow from financing activities | ||||
| Other loans | (13,765) | 6,700,881 | ||
| Dividends paid | (14,160,152) | (5,078,792) | ||
| Issued debt instruments | (22,830) | 1,626,167 | ||
| Net cash generated from (used in) financing activities | (14,196,747) | 3,248,256 | ||
| Net (decrease) increase in cash and cash equivalent during the period | 100,019,191 | 66,739,374 | ||
| Beginning balance of cash and cash equivalent | 226,610,721 | 234,317,913 | ||
| Cash and cash equivalent at the end of the period | 326,629,912 | 301,057,287 | ||
| Cash and cash equivalent comprise: | ||||
| Cash and balances at the central bank | 9 | 68,810,514 | 36,731,091 | |
| Due from banks | 314,450,806 | 292,723,938 | ||
| Treasury bills and other governmental notes | 11 | 116,419,815 | 119,754,167 | |
| Obligatory reserve balance with central bank | (43,885,546) | (19,531,282) | ||
| Due from banks with maturity more than three months | (14,867,792) | (8,740,302) | ||
| Treasury bills and other governmental notes with maturity more than three months | (114,297,885) | (119,880,325) | ||
| Total cash and cash equivalent | 326,629,912 | 301,057,287 | ||
| Condensed Consolidated Interim statement of changes in shareholders' equity | ||||||||||||||
| Mar. 31, 2024 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total |
| Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | (670,972) | 21,155 | (16,868,691) | 15,230 | 29,993,331 | 1,486,010 | 148,353 | 90,481,393 | 160,073 | 90,641,466 |
| Transferred to reserves | - | 1,438,320 | 21,958,960 | - | - | 1,663 | - | - | (23,398,943) | - | - | - | - | - |
| Net profit for the period | - | - | - | - | - | - | - | - | 11,924,434 | - | - | 11,924,434 | 456 | 11,924,890 |
| Dividends paid | - | - | - | - | - | - | - | - | (5,366,429) | - | - | (5,366,429) | - | (5,366,429) |
| Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 1,915,786 | - | - | - | - | 1,915,786 | - | 1,915,786 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 21,718 | (21,718) | - | - | - | - | - |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 744,813 | - | - | - | - | 744,813 | - | 744,813 |
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 300,000 | - | 300,000 | - | 300,000 |
| Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | 831,452 | 831,452 | (321) | 831,131 |
| Ending balance | 30,195,010 | 6,208,674 | 61,799,667 | 1,550,906 | (670,972) | 22,818 | (14,208,092) | 36,948 | 13,130,675 | 1,786,010 | 979,805 | 100,831,449 | 160,208 | 100,991,657 |
| Mar. 31, 2025 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total |
| Beginning balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | (670,972) | 22,818 | (7,145,283) | 17,924 | 56,791,883 | 1,868,235 | 1,137,720 | 152,636,277 | 183,044 | 152,819,321 |
| Transferred to reserves | - | 2,771,284 | 18,971,298 | - | - | 2,246 | - | - | (21,744,828) | - | - | - | - | - |
| Dividends paid | - | - | - | - | - | - | - | - | (14,714,434) | - | - | (14,714,434) | - | (14,714,434) |
| Net profit for the period | - | - | - | - | - | - | - | - | 16,631,775 | - | - | 16,631,775 | 1,394 | 16,633,169 |
| Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | (26,186) | - | - | - | - | - |
| Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 2,409,316 | - | - | - | - | 2,409,316 | 82,006 | 2,491,322 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 841,687 | - | - | - | - | 841,687 | - | 841,687 |
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 316,185 | - | 316,185 | - | 316,185 |
| Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | (169,708) | (169,708) | - | (169,708) |
| Ending balance | 30,431,580 | 8,979,958 | 81,394,090 | 1,577,092 | (670,972) | 25,064 | (3,894,280) | 15,296 | 36,940,838 | 2,184,420 | 968,012 | 157,951,098 | 266,444 | 158,217,542 |
Recent news on Commercial International Bank Egypt CIB
See all newsEgypt's Commercial International Bank's Kenya unit aims to triple market share in two years
Brief: EGX Changes Launch Date For Futures Contracts On CIB And TMG Holding To June 21
Brief: EGX To Launch Derivatives For CIB & TMG By 18 June
Mideast Stocks: Most Gulf markets surge on US-Iran peace deal expectations
Mideast Stocks: Gulf bourses fall as US-Iran uncertainty keeps investors cautious